# DHA Supplementation in Patients With STGD3

> **NCT00420602** · NA · COMPLETED · sponsor: **University of Utah** · enrollment: 11 (actual)

## Conditions studied

- Dominantly Inherited Stargardt's Disease (STGD3)

## Interventions

- **DIETARY_SUPPLEMENT:** Over the counter DHA/EPA dietary supplementation

## Key facts

- **NCT ID:** NCT00420602
- **Lead sponsor:** University of Utah
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-09-21
- **Primary completion:** 2017-12-27
- **Final completion:** 2017-12-27
- **Target enrollment:** 11 (ACTUAL)
- **Last updated:** 2018-05-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00420602

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00420602, "DHA Supplementation in Patients With STGD3". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00420602. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*